209 related articles for article (PubMed ID: 19552697)
1. Sialylated ligands on pathogenic Trypanosoma cruzi interact with Siglec-E (sialic acid-binding Ig-like lectin-E).
Erdmann H; Steeg C; Koch-Nolte F; Fleischer B; Jacobs T
Cell Microbiol; 2009 Nov; 11(11):1600-11. PubMed ID: 19552697
[TBL] [Abstract][Full Text] [Related]
2. Molecular interaction of Siglecs (sialic acid-binding Ig-like lectins) with sialylated ligands on Trypanosoma cruzi.
Jacobs T; Erdmann H; Fleischer B
Eur J Cell Biol; 2010 Jan; 89(1):113-6. PubMed ID: 19910077
[TBL] [Abstract][Full Text] [Related]
3. Involvement of sulfates from cruzipain, a major antigen of Trypanosoma cruzi, in the interaction with immunomodulatory molecule Siglec-E.
Ferrero MR; Heins AM; Soprano LL; Acosta DM; Esteva MI; Jacobs T; Duschak VG
Med Microbiol Immunol; 2016 Feb; 205(1):21-35. PubMed ID: 26047932
[TBL] [Abstract][Full Text] [Related]
4. Trypanosoma cruzi trans-sialidase potentiates T cell activation through antigen-presenting cells: role of IL-6 and Bruton's tyrosine kinase.
Gao W; Pereira MA
Eur J Immunol; 2001 May; 31(5):1503-12. PubMed ID: 11465107
[TBL] [Abstract][Full Text] [Related]
5. Parasite-derived trans-sialidase binds to heart tissue in Trypanosoma cruzi-infected animals.
Alcântara-Neves NM; Ribeiro-dos-Santos R; Amor AL; Uemura H; Silva-Neto SJ; Eichinger D; Pontes-de-Carvalho L
Microb Pathog; 2004 Nov; 37(5):273-8. PubMed ID: 15519048
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional properties of Trypanosoma trans-sialidase.
Schenkman S; Eichinger D; Pereira ME; Nussenzweig V
Annu Rev Microbiol; 1994; 48():499-523. PubMed ID: 7826016
[TBL] [Abstract][Full Text] [Related]
7. Trans-sialidase and mucins of Trypanosoma cruzi: an important interplay for the parasite.
Giorgi ME; de Lederkremer RM
Carbohydr Res; 2011 Sep; 346(12):1389-93. PubMed ID: 21645882
[TBL] [Abstract][Full Text] [Related]
8. Lactose derivatives are inhibitors of Trypanosoma cruzi trans-sialidase activity toward conventional substrates in vitro and in vivo.
Agustí R; París G; Ratier L; Frasch AC; de Lederkremer RM
Glycobiology; 2004 Jul; 14(7):659-70. PubMed ID: 15070857
[TBL] [Abstract][Full Text] [Related]
9. [TH1 response in the experimental infection with Trypanosoma cruzi].
Cardoni RL; Antúnez MI; Abrami AA
Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
[TBL] [Abstract][Full Text] [Related]
10. T rypanosoma cruzi trans-sialidase as a multifunctional enzyme in Chagas' disease.
Dc-Rubin SS; Schenkman S
Cell Microbiol; 2012 Oct; 14(10):1522-30. PubMed ID: 22747789
[TBL] [Abstract][Full Text] [Related]
11. A neuraminidase from Trypanosoma cruzi removes sialic acid from the surface of mammalian myocardial and endothelial cells.
Libby P; Alroy J; Pereira ME
J Clin Invest; 1986 Jan; 77(1):127-35. PubMed ID: 3080470
[TBL] [Abstract][Full Text] [Related]
12. Central role of extracellular signal-regulated kinase and Toll-like receptor 4 in IL-10 production in regulatory dendritic cells induced by Trypanosoma cruzi.
Poncini CV; Giménez G; Pontillo CA; Alba-Soto CD; de Isola EL; Piazzón I; Cappa SM
Mol Immunol; 2010 Jul; 47(11-12):1981-8. PubMed ID: 20537708
[TBL] [Abstract][Full Text] [Related]
13. Parasite-host glycan interactions during Trypanosoma cruzi infection: trans-Sialidase rides the show.
Campetella O; Buscaglia CA; Mucci J; Leguizamón MS
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165692. PubMed ID: 31972227
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of a virulence factor, the trans-sialidase, by the main Trypanosoma cruzi phylogenetic lineages.
Risso MG; Garbarino GB; Mocetti E; Campetella O; Gonzalez Cappa SM; Buscaglia CA; Leguizamon MS
J Infect Dis; 2004 Jun; 189(12):2250-9. PubMed ID: 15181573
[TBL] [Abstract][Full Text] [Related]
15. The trans-sialidase, the major Trypanosoma cruzi virulence factor: Three decades of studies.
Freire-de-Lima L; Fonseca LM; Oeltmann T; Mendonça-Previato L; Previato JO
Glycobiology; 2015 Nov; 25(11):1142-9. PubMed ID: 26224786
[TBL] [Abstract][Full Text] [Related]
16. The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents.
Tribulatti MV; Mucci J; Van Rooijen N; Leguizamón MS; Campetella O
Infect Immun; 2005 Jan; 73(1):201-7. PubMed ID: 15618155
[TBL] [Abstract][Full Text] [Related]
17. Kinetic analysis of antigen-specific immune responses in resistant and susceptible mice during infection with Trypanosoma cruzi.
Hoft DF; Lynch RG; Kirchhoff LV
J Immunol; 1993 Dec; 151(12):7038-47. PubMed ID: 8258708
[TBL] [Abstract][Full Text] [Related]
18. Endothelial cell signalling induced by trans-sialidase from Trypanosoma cruzi.
Dias WB; Fajardo FD; Graça-Souza AV; Freire-de-Lima L; Vieira F; Girard MF; Bouteille B; Previato JO; Mendonça-Previato L; Todeschini AR
Cell Microbiol; 2008 Jan; 10(1):88-99. PubMed ID: 17672865
[TBL] [Abstract][Full Text] [Related]
19. Immune system pathogenesis is prevented by the neutralization of the systemic trans-sialidase from Trypanosoma cruzi during severe infections.
Risso MG; Pitcovsky TA; Caccuri RL; Campetella O; Leguizamón MS
Parasitology; 2007 Apr; 134(Pt 4):503-10. PubMed ID: 17166319
[TBL] [Abstract][Full Text] [Related]
20. In vivo infection by Trypanosoma cruzi: the conserved FLY domain of the gp85/trans-sialidase family potentiates host infection.
Tonelli RR; Torrecilhas AC; Jacysyn JF; Juliano MA; Colli W; Alves MJ
Parasitology; 2011 Apr; 138(4):481-92. PubMed ID: 21040619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
